ACHE and Alzheimer disease: Among the pharmacotherapies used for the management of AD, the employment of acetylcholinesterase inhibitors (AChEI), able to block ACh metabolism and thus increase both the level and duration of the neurotransmitter action, represents a reasonable approach to treating AD and other forms of dementia.